Your browser doesn't support javascript.
loading
Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products.
Mori, Filippo; Salvatore, Alfonso; Ascione, Ester; Di Marzo, Raffaele; Fox, Bernard.
Affiliation
  • Mori F; Department of Research and Innovation, Kedrion S.p.A., Lucca, Italy.
  • Salvatore A; Department of Industrial Development, Kedrion S.p.A., Naples, Italy.
  • Ascione E; Department of Industrial Development, Kedrion S.p.A., Naples, Italy.
  • Di Marzo R; Therapeutic Area Lead, Global Medical Affairs Department, Kedrion S.p.A., Lucca, Italy.
  • Fox B; Biotherapeutics Division, National Institute for Biological Standards and Control (NIBSC), Potters Bar, Herts, UK.
Vox Sang ; 117(4): 624-625, 2022 04.
Article in En | MEDLINE | ID: mdl-34699082
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Rho(D) Immune Globulin Limits: Humans Language: En Journal: Vox Sang Year: 2022 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Rho(D) Immune Globulin Limits: Humans Language: En Journal: Vox Sang Year: 2022 Type: Article Affiliation country: Italy